Meeting Recording
Dr Vikas Reddy will educate us about where Empagliflozin fits in the appropriate treatment of patients with heart failure with preserved ejection fraction. Heart failure, like diabetes, has become so complex with so many options, it will be instructive to try to put all of this into focus in order to make better clinical decisions for patients.
Following Dr. Reddy, Dr. Gahm discusses some of the latest geriatric topics such as updates on controversial FDA rulings and an uptick in C. Auris infections.
Dapagliflozin for HF-pEF JAMA 23.pdf
Aprocitentan New HTN Rx 24.docx
Aduhelm discontinuation 24.docx
Microplastics in Plaque 24.docx
Ingrezza for HD FDA 23.docx
CHF Guidelines 23.docx